Laboratory of Medicinal Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.
Eur J Med Chem. 2010 Jun;45(6):2191-7. doi: 10.1016/j.ejmech.2010.01.057. Epub 2010 Jan 29.
3alpha-methoxyserrat-14-en-21beta-ol (1) and 3beta-methoxyserrat-14-en-21beta-ol (2) and their conjugates with curcumin, kojic acid, quercetin, and baicalein (3-18), as well as new analogs (19-24) derived from 1 and 2, were tested for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). The inhibitory effects of 16 (IC50=330 mol ratio/32 pmol/TPA), 9 (IC50=335), 10 (IC50=338), and 15 (IC50=350) were stronger than those of the other compounds and the positive control, oleanolic acid (IC50=449). Compounds 15 and 16, which are conjugates of one molecule each of 1 or 2 and quercetin, inhibited mouse skin tumor promotion in an in vivo two-stage carcinogenesis model. The in vivo two-stage mouse skin carcinogenesis test employed 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter.
3α-甲氧基-14-烯-21β-醇(1)和 3β-甲氧基-14-烯-21β-醇(2)及其与姜黄素、曲酸、槲皮素和黄芩素(3-18)的轭合物,以及源自 1 和 2 的新类似物(19-24),都被测试了其对 12-O-十四烷酰佛波醇-13-醋酸酯(TPA)诱导的 Epstein-Barr 病毒早期抗原(EBV-EA)激活的抑制作用。16(IC50=330 摩尔比/32 pmol/TPA)、9(IC50=335)、10(IC50=338)和 15(IC50=350)的抑制作用强于其他化合物和阳性对照齐墩果酸(IC50=449)。15 和 16 是 1 或 2 与槲皮素的单分子轭合物,它们在体内两阶段致癌模型中抑制了小鼠皮肤肿瘤的促进作用。体内两阶段小鼠皮肤致癌试验采用 7,12-二甲基苯并[a]蒽(DMBA)作为起始剂,TPA 作为促进剂。